Somatic mutations were identified in the JNK pathway via large-scale sequencing analyses of human tumor cells [19], [20], and JNK3 encoding gene (MAPK10) has been speculated to be a putative tumor suppressor gene as almost half of the brain tumors that were examined included mutations [21]. This evidence concerns the gene MAPK8 and neoplasm.